Alder Biopharmaceuticals Inc

CIK 1423824 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alder Biopharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Feb 13, 2020SC 13G/A0001387131-20-001549
Nov 1, 201915-12B0001193125-19-281545
Oct 31, 2019SC 13G0000902664-19-004139
Oct 25, 2019SC 13D/A0001193125-19-273714
Oct 24, 201940001209191-19-053921
Oct 24, 201940001209191-19-053922
Oct 24, 201940001209191-19-053913
Oct 24, 201940001209191-19-053912
Oct 24, 201940001209191-19-053940
Oct 24, 2019SC 13D/A0001104659-19-056127
Oct 24, 201940001209191-19-053952
Oct 24, 201940001209191-19-053917
Oct 24, 201940001209191-19-053944
Oct 24, 201940001209191-19-053920
Oct 24, 201940001104659-19-056193
Oct 24, 201940001209191-19-053911
Oct 24, 201940001209191-19-053904
Oct 24, 201940001209191-19-053916
Oct 24, 201940001209191-19-053918
Oct 24, 201940001209191-19-053919
Oct 24, 201940000899243-19-025918
Oct 22, 201925-NSE0001354457-19-000537
Oct 22, 2019S-8 POS0001193125-19-271698
Oct 22, 2019SC TO-T/A0001193125-19-271317
Oct 22, 2019S-8 POS0001193125-19-271710